4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000108
Chief Medical Officer sold 7,000 shares at an average $74.81 ($523,648)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Option exercise 10b5-1 | +3,500 | $6.84 | $23,940 | 35,271 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Option exercise 10b5-1 | +3,500 | $7.80 | $27,300 | 38,771 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Sale 10b5-1 | −2,853 | $73.89 | $210,806 | 35,918 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Sale 10b5-1 | −1,847 | $74.69 | $137,957 | 34,071 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Sale 10b5-1 | −1,400 | $75.48 | $105,677 | 32,671 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Sale 10b5-1 | −700 | $76.67 | $53,666 | 31,971 | D |
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Sale 10b5-1 | −200 | $77.71 | $15,542 | 31,771 | D |
| Derivatives | |||||||
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 190,063 | D | ||
| Goncalves Joana Chief Medical Officer | 2026-10-15 | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 161,492 | D | ||
| Open-market sales · 7,000 sh · avg $74.81 · $523,648 | |||||||
Loading xslF345X06/form4.xml…